About
Mike has spent more than 35 years inside pharma and biotech's biggest positioning decisions, with direct involvement in more than half of the blockbuster launches of the last 20 years. He founded IDEA Pharma, created the Pharmaceutical Innovation Index, and wrote POSITION, the field guide to pharmaceutical positioning.
Career
One question has run through the whole career: why do some molecules become great medicines, while equally good science ends up somewhere different?
A genetics degree at the University of Newcastle-upon-Tyne, and a Geordie for life. Along the way he set up a UK college American football league.
Years in pharmaceutical marketing and branding, which ended with a resignation on principle after the company he worked for was acquired. That decision became the opening for what came next.
A consultancy built around positioning and path-to-market strategy, from early to late-phase development. IDEA went on to shape the strategy behind many of the industry's biggest launches, from Cymbalta to luspatercept.
An annual ranking of how well pharma companies turn invention into launched, valuable medicines. It shifted the conversation from how much science a company has to how well it gets that science to patients.
A next-generation contract research organisation, focused on finding the best route to market for a drug while it is still in development.
Deep Positioning set out why the gap between strong science and a weak position exists. POSITION, the field guide, shows how to close it with eight levers that shape the market before the product arrives.
Leading Then, If…, advising biotechs and translational research programmes, and writing about what the market is pricing next.
Current roles
Advisory work across companion-animal oncology, health policy, academic drug development and early-stage biotech.
His current company, and the base for his advisory and writing work.
Precision medicine for dogs with cancer.
The nonprofit, nonpartisan think tank working on health, finance and the economy.
Stanford's programme for turning academic discoveries into medicines for patients.
Early-stage companies deciding what their first programmes should become.
Positioning and path-to-market strategy, and the industry's annual measure of innovation.
Recognition
Lists chosen by peers and readers across biopharma, not paid awards.
Top10
The Medicine Maker Power List
Most influential people in biopharmaceuticals.
202320242025
Top20
Global Power List 20
The top 20 inspirational medicine makers in biopharmaceuticals, The Medicine Maker.
20202021
Top100
Global Power List 100
The 100 most influential people in healthcare, The Medicine Maker.
201720182019
Top10
Top 10 Innovators in Pharma
Named by PharmaPhorum.
2012
Lifetime
PharmaVOICE Red Jacket
100 Most Inspiring People in Healthcare, and a lifetime Red Jacket winner.
2011201320152016
Off the clock
For advisory work, speaking and media enquiries, get in touch. Or start with the book.